[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350445-105":59,"doc-detail-350445-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","development-and-validation-of-a-preoperative-glycolipid-metabolism-based-nomogram-for-predicting-postoperative-recurrence-in-primary-glioma-research-open-access","Development and validation of a preoperative glycolipid metabolism-based nomogram for predicting postoperative recurrence in primary glioma - Research Open Access","","Glioma recurrence after surgery remains common and strongly affects survival. The study focuses on metabolic reprogramming, particularly abnormalities in glycolipid metabolism, and evaluates the triglyceride-glucose (TyG) index as a marker of insulin resistance and metabolic disturbance. Using 302 primary glioma patients, glycolipid parameters are selected with Bootstrap-LASSO and combined with clinical factors into a nomogram to predict 1-, 2-, and 3-year recurrence-free survival.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/development-and-validation-of-a-preoperative-glycolipid-metabolism-based-nomogram-for-predicting-postoperative-recurrence-in-primary-glioma-research-open-access/350445/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/development-and-validation-of-a-preoperative-glycolipid-metabolism-based-nomogram-for-predicting-postoperative-recurrence-in-primary-glioma-research-open-access/350445.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical problem does the study address?","Question",{"text":112,"@type":113},"It addresses the high rate of glioma recurrence after surgery and the resulting impact on patient survival. The goal is to better predict recurrence risk to support individualized monitoring and interventions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the predictive nomogram developed?",{"text":117,"@type":113},"Glycolipid metabolic parameters were identified using Bootstrap resampling with LASSO regression to generate a stabilized BSL-Score. Clinical variables significant in univariate Cox regression were entered into multivariate Cox regression, and the independent indicators were integrated into a nomogram.",{"name":119,"@type":110,"acceptedAnswer":120},"How well did the model perform in validation?",{"text":121,"@type":113},"In the training cohort, the nomogram showed a C-index of 0.747 and AUC values for 1-, 2-, and 3-year RFS. Internal and independent validation cohorts produced C-indices of 0.703 and 0.785, respectively, with calibration and decision curve analyses supporting clinical utility.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350445,1790798476,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Liu et al. Lipids in Health and Disease (2026) 25:153 Lipids in Health and Disease  \n[https://doi.org/10.1186/s12944-026-02968-5](https://doi.org/10.1186/s12944-026-02968-5)  \nRESEARCH Open Access  \nDevelopment and validation of a preoperative  glycolipid metabolism-based nomogram for predicting postoperative recurrence in primary glioma: a retrospective cohort  \nstudy  \nHaobin Liu1,2, Yuxiao Wu1,2, Haoyu Sun1,2, Qunyu Sun3, Mingguang Wang4, Jinling Zhang5* and Zhong Lu6*  \nAbstract  \nBackground Glioma recurrence after surgery remains prevalent, significantly impacting patient survival. Tumor progression is closely linked to metabolic reprogramming, especially abnormalities involving glycolipid metabolism. The triglyceride-glucose (TyG) index accurately indicates insulin resistance (IR) and metabolic disturbances. Although these metabolic indicators are prognostically valuable in various cancers, their role in forecasting glioma recurrence is still insufficiently investigated.  \nMethods The medical records of 302 primary glioma patients who received surgical treatment at Linyi People’s Hospital from 2016 to 2024 were retrospectively reviewed. Participants admitted to one ward (n = 236) were randomly assigned to either a training set (n = 141) or an internal validation set (n = 95) . Another distinct ward provided patients (n = 66) for an independent internal validation group. In the training cohort, essential glycolipid metabolic parameters were identified via Bootstrap resampling combined with Least Absolute Shrinkage and Selection Operator (LASSO) regression, yielding a stabilized Bootstrap-LASSO Score (BSL-Score) . Clinical variables alongside this score were subjected to univariate Cox regression analysis, and variables with statistical significance (P \u003C 0. 05) progressed into multivariate Cox regression to pinpoint independent prognostic indicators. Subsequently, these independent indicators were integrated into a nomogram to forecast 1-, 2-, and 3-year postoperative recurrence-free survival (RFS) . Model performance was confirmed through concordance index (C-index) evaluation, time-dependent receiver operating characteristic (ROC) analyses, calibration curves, and decision curve analysis (DCA), with Bootstrap correction utilized for the C-index.  \nResults In the training cohort (n = 141), the nomogram achieved a C-index of 0.747 (95% CI: 0 .676–0. 818) and area under the curve (AUC) values of 0 . 832, 0 . 732, and 0.732 for 1-, 2-, and 3-year RFS, respectively. In internal validation  \n*Correspondence:  \nJinling Zhang [jinlingzhang_931@163.com](jinlingzhang_931@163.com)[ ](jinlingzhang_931@163.com)Zhong Lu[luzhong@sdsmu.edu.cn](luzhong@sdsmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLiu et al. Lipids in Health and Disease (2026) 25:153 Page 2 of 15  \n(n = 9","cbCaiuU6X7O5xo6h","https://ap.wps.com/l/cbCaiuU6X7O5xo6h","pdf",4060861,15,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Clinical importance of predicting recurrence\n## Need for robust predictive models","[{\"question\":\"What clinical problem does the study address?\",\"answer\":\"It addresses the high rate of glioma recurrence after surgery and the resulting impact on patient survival. The goal is to better predict recurrence risk to support individualized monitoring and interventions.\"},{\"question\":\"How was the predictive nomogram developed?\",\"answer\":\"Glycolipid metabolic parameters were identified using Bootstrap resampling with LASSO regression to generate a stabilized BSL-Score. Clinical variables significant in univariate Cox regression were entered into multivariate Cox regression, and the independent indicators were integrated into a nomogram.\"},{\"question\":\"How well did the model perform in validation?\",\"answer\":\"In the training cohort, the nomogram showed a C-index of 0.747 and AUC values for 1-, 2-, and 3-year RFS. Internal and independent validation cohorts produced C-indices of 0.703 and 0.785, respectively, with calibration and decision curve analyses supporting clinical utility.\"}]","Development and validation of a preoperative glycolipid metabolism-based nomogram for predicting postoperative recurrence in primary glioma - Research Open Access | PDF",1790089079,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c54b927e3c042d456a4d4672ae4b0eb.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95b59becf60e61058fa5d370ec9bf0b0.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/980ea02318135fef705bcab5c95ec36a.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d111bc580b06043470c67f18afd1634.webp",980,1306]